IGF2BP3 and lung cancer: Specifically, IGF2BP3 regulates the alternative splicing patterns of PKM genes, known for aberrant splicing in various cancers, potentially promoting lung tumourigenesis and offering a novel therapeutic target for patients with lung cancer.128